At a Glance

At a Glance

genOway designs genetically modified mouse, rat, and cell line models of the highest physiological relevancy for bio-pharmaceutical and academic researchers in:

28
countries worldwide
380
academic institutions
13
EU projects

170
Life Sciences
companies
17
of the Top 20
pharma

Humanized Immune Checkpoint Mouse Models

Humanized Immune Checkpoint Mouse Models

A catalog of reliable and efficient translational mouse models for immunotherapy expressing humanized immune checkpoints.

BRGSF-HIS Mouse Model

BRGSF-HIS Mouse Model

Immunodeficient mice displaying functional human lymphoid and myeloid compartments without graft versus host disease and other side effects.

Double-humanized HSA/hFcRn Mouse Model

Double-humanized HSA/hFcRn Mouse Model

A double-humanized serum albumin/neonatal Fc receptor mouse model that maintains an autologous receptor-ligand interaction to assess PK/PD studies.

  • "We have worked with genOway in different projects for several years, and we are very impressed by their competence,..."

    Prof. Maria T. DIAZ-MECO

    Lab Head at Sanford Burnham Prebys Medical Discovery Institute

    > read full testimonial
    more
  • "genOway is the Mercedes Benz of transgenic outsourcing companies."

    Prof. Robert TERKELTAUB

    Director at UC San Diego School of Medicine

    > read full testimonial
    more
  • "We were highly impressed by the expert manner in which genOway’s scientists managed what I felt to be a rather..."

    Prof. Simon C. ROBSON

    Director at Beth Israel Deaconess Medical Center

    > read full testimonial
    more
  • "I am truly impressed with the responsiveness and help that I have obtained from genOway. It has been a pleasure to work..."

    Prof. Bellur S. PRABHAKAR

    Associate Dean at University of Illinois College of Medicine

    > read full testimonial
    more
  • "Leader for the development of transgenic mice and rats, genOway is a very reliable biotechnology company. Their main..."

    Prof. Shomi BHATTACHARYA

    Director of Cabimer

    > read full testimonial
    more
  • "genOway's technology is excellent and their mouse business is impressive. We are looking forward to working..."

    Dr. Ulrich THIBAUT

    Supervisory Board of Glycotope GmbH Berlin

    > read full testimonial
    more
  • "genOway is a leading company in the field of genetically modified mouse and rat models. Its technology platform is..."

    Prof. Pier Paolo DI FIORE

    IFOM-IEO Campus, University of Milan

    > read full testimonial
    more
  • "genOway has carried out several projects for us. This collaboration has been very successful. Not just because we have..."

    Prof. Arne KLUNGLAND

    Lab Head at Oslo University Hospital

    > read full testimonial
    more
  • "genOway has a professional attitude toward its customers. We had really appreciated their innovative technologies and..."

    Prof. Ivan DIKIC

    Director at Goethe University Frankfurt am Main

    > read full testimonial
    more
  • "It goes without saying that knockout technologies are an indispensible research tool in Hepatology. In this regard we..."

    Prof. Dr. Dieter HÄUSSINGER

    Director at Heinrich Heine University Düsseldorf

    > read full testimonial
    more
  • "genOway provides us with a very professional services within the expected timelines and high quality scientific..."

    Prof. Gerd WALZ

    Director at Albert Ludwigs University Freiburg

    > read full testimonial
    more
  • "For more than two years we have worked with the scientific staff at genOway appreciating their fruitful and constant..."

    Prof. Gianfranco SEBASTIO

    University of Naples Federico II

    > read full testimonial
    more
  • "genOway has already supplied us with several difficult-to-make knockout cell lines. We are impressed by the speed and..."

    Prof. Hans CLEVERS

    Director Research of Princess Maxima Center

    > read full testimonial
    more
  • "Mouse knock-out technology is an important step in cancer research, it provides relevant answers to scientific questions..."

    Dr. Luisa LANFRANCONE

    IFOM-IEO Campus, University of Milan

    > read full testimonial
    more
  • "I ascertain that genOway has provided extremely efficient and competent services to us and we will very likely use them..."

    Prof. Ludwig NEYSES

    Chair of Medicine at University of Manchester

    > read full testimonial
    more
  • "I have never witnessed such proactive behavior with customers. genOway truly understand our challenges and is equipped..."

    Dr. Carla BOCCACCIO

    University of Torino Medical School

    > read full testimonial
    more
  • "genOway is a very reliable company. They provide a very flexible service customized to our needs and expectation. I..."

    Dr. Angela GRECO

    Director at IRCCS Foundation Milan

    > read full testimonial
    more
  • "Without you it would have been impossible for us to establish this transgenic mouse from the EUCOMM ES cells. I was most..."

    Dr. Matthias HUNDT

    Instructor at La Jolla Institute for Allergy & Immunology

    > read full testimonial
    more
  • "With the idea to develop a mouse model for the rare human disease ALD, we reached out to genOway to help us in finding..."

    Dr. Stephan KEMP

    Associate Professor at Academic Medical Center (AMC)

    > read full testimonial
    more
  • "genOway has not only successful provided this service, but we have benefited a great deal from their consultation,..."

    Dr. Paul RILEY

    Chair of Development and Cell Biology at Oxford University

    > read full testimonial
    more
Customized mouse, rat & cell line models

Customized mouse, rat & cell line models

Designed to specifically address your research project with the support and advice of our scientific team.

Catalog Cell Lines

Catalog Cell Lines

Humanized, Knockout and reporter immune checkpoint cell lines for tumor-growth essays, syngeneic models, and in-vitro mechanistic studies.

CD3 T-cell Engager Mouse Models

CD3 T-cell Engager Mouse Models

Physiologically relevant models to assess and evaluate T-cell engagement efficacy for innovative therapeutics in cancer immunotherapies.

Partner For Your EU Research Project

Partner For Your EU Research Project

Looking for an experienced and qualified industrial partner for your EU project?

We have successfully participated in 13 EU programs, and can help you build a robust European research consortium structure.